A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Clinical trial NCT05691478 · SUSPENDED

Trial details

NCT number: NCT05691478
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

High Grade Osteosarcoma Localized Osteosarcoma Metastatic Osteosarcoma Secondary Osteosarcoma

Start date: 2023-03-03
Primary completion: 2030-03-20
Enrollment: 1122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.